Literature DB >> 26735901

Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies.

James S Ware1, Jian Li, Erica Mazaika, Christopher M Yasso, Tiffany DeSouza, Thomas P Cappola, Emily J Tsai, Denise Hilfiker-Kleiner, Chizuko A Kamiya, Francesco Mazzarotto, Stuart A Cook, Indrani Halder, Sanjay K Prasad, Jessica Pisarcik, Karen Hanley-Yanez, Rami Alharethi, Julie Damp, Eileen Hsich, Uri Elkayam, Richard Sheppard, Angela Kealey, Jeffrey Alexis, Gautam Ramani, Jordan Safirstein, John Boehmer, Daniel F Pauly, Ilan S Wittstein, Vinay Thohan, Mark J Zucker, Peter Liu, John Gorcsan, Dennis M McNamara, Christine E Seidman, Jonathan G Seidman, Zoltan Arany.   

Abstract

Background Peripartum cardiomyopathy shares some clinical features with idiopathic dilated cardiomyopathy, a disorder caused by mutations in more than 40 genes, including TTN, which encodes the sarcomere protein titin. Methods In 172 women with peripartum cardiomyopathy, we sequenced 43 genes with variants that have been associated with dilated cardiomyopathy. We compared the prevalence of different variant types (nonsense, frameshift, and splicing) in these women with the prevalence of such variants in persons with dilated cardiomyopathy and with population controls. Results We identified 26 distinct, rare truncating variants in eight genes among women with peripartum cardiomyopathy. The prevalence of truncating variants (26 in 172 [15%]) was significantly higher than that in a reference population of 60,706 persons (4.7%, P=1.3×10(-7)) but was similar to that in a cohort of patients with dilated cardiomyopathy (55 of 332 patients [17%], P=0.81). Two thirds of identified truncating variants were in TTN, as seen in 10% of the patients and in 1.4% of the reference population (P=2.7×10(-10)); almost all TTN variants were located in the titin A-band. Seven of the TTN truncating variants were previously reported in patients with idiopathic dilated cardiomyopathy. In a clinically well-characterized cohort of 83 women with peripartum cardiomyopathy, the presence of TTN truncating variants was significantly correlated with a lower ejection fraction at 1-year follow-up (P=0.005). Conclusions The distribution of truncating variants in a large series of women with peripartum cardiomyopathy was remarkably similar to that found in patients with idiopathic dilated cardiomyopathy. TTN truncating variants were the most prevalent genetic predisposition in each disorder.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26735901      PMCID: PMC4797319          DOI: 10.1056/NEJMoa1505517

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  30 in total

1.  Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy.

Authors:  Ana Morales; Thomas Painter; Ran Li; Jill D Siegfried; Duanxiang Li; Nadine Norton; Ray E Hershberger
Journal:  Circulation       Date:  2010-05-10       Impact factor: 29.690

2.  Familial occurrence of postpartal heart failure.

Authors:  J A PIERCE; B O PRICE; J W JOYCE
Journal:  Arch Intern Med       Date:  1963-05

3.  Distinct clinical and histopathological presentations of Danon cardiomyopathy in young women.

Authors:  Amir Toib; Dorothy K Grange; Beth A Kozel; Gregory A Ewald; Frances V White; Charles E Canter
Journal:  J Am Coll Cardiol       Date:  2010-01-26       Impact factor: 24.094

Review 4.  Familial occurrence of peripartum cardiomyopathy.

Authors:  W Pearl
Journal:  Am Heart J       Date:  1995-02       Impact factor: 4.749

5.  From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline.

Authors:  Geraldine A Van der Auwera; Mauricio O Carneiro; Christopher Hartl; Ryan Poplin; Guillermo Del Angel; Ami Levy-Moonshine; Tadeusz Jordan; Khalid Shakir; David Roazen; Joel Thibault; Eric Banks; Kiran V Garimella; David Altshuler; Stacey Gabriel; Mark A DePristo
Journal:  Curr Protoc Bioinformatics       Date:  2013

Review 6.  Peripartum cardiomyopathy.

Authors:  Karen Sliwa; James Fett; Uri Elkayam
Journal:  Lancet       Date:  2006-08-19       Impact factor: 79.321

7.  Glycogen storage diseases presenting as hypertrophic cardiomyopathy.

Authors:  Michael Arad; Barry J Maron; Joshua M Gorham; Walter H Johnson; J Philip Saul; Antonio R Perez-Atayde; Paolo Spirito; Gregory B Wright; Ronald J Kanter; Christine E Seidman; J G Seidman
Journal:  N Engl J Med       Date:  2005-01-27       Impact factor: 91.245

8.  A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy.

Authors:  Denise Hilfiker-Kleiner; Karol Kaminski; Edith Podewski; Tomasz Bonda; Arnd Schaefer; Karen Sliwa; Olaf Forster; Anja Quint; Ulf Landmesser; Carola Doerries; Maren Luchtefeld; Valeria Poli; Michael D Schneider; Jean-Luc Balligand; Fanny Desjardins; Aftab Ansari; Ingrid Struman; Ngoc Q N Nguyen; Nils H Zschemisch; Gunnar Klein; Gerd Heusch; Rainer Schulz; Andres Hilfiker; Helmut Drexler
Journal:  Cell       Date:  2007-02-09       Impact factor: 41.582

9.  Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor.

Authors:  William McLaren; Bethan Pritchard; Daniel Rios; Yuan Chen; Paul Flicek; Fiona Cunningham
Journal:  Bioinformatics       Date:  2010-06-18       Impact factor: 6.937

10.  Cardiac angiogenic imbalance leads to peripartum cardiomyopathy.

Authors:  Ian S Patten; Sarosh Rana; Sajid Shahul; Glenn C Rowe; Cholsoon Jang; Laura Liu; Michele R Hacker; Julie S Rhee; John Mitchell; Feroze Mahmood; Philip Hess; Caitlin Farrell; Nicole Koulisis; Eliyahu V Khankin; Suzanne D Burke; Igor Tudorache; Johann Bauersachs; Federica del Monte; Denise Hilfiker-Kleiner; S Ananth Karumanchi; Zoltan Arany
Journal:  Nature       Date:  2012-05-09       Impact factor: 49.962

View more
  137 in total

Review 1.  The Role of Genetics in Peripartum Cardiomyopathy.

Authors:  Yi Zhen Joan Lee; Daniel P Judge
Journal:  J Cardiovasc Transl Res       Date:  2017-08-03       Impact factor: 4.132

2.  Cardiomyopathies: Genetic overlap between peripartum and dilated cardiomyopathies.

Authors:  Gregory B Lim
Journal:  Nat Rev Cardiol       Date:  2016-01-22       Impact factor: 32.419

3.  Advances in Cardiovascular Health in Women over the Past Decade: Guideline Recommendations for Practice.

Authors:  Pejman Raeisi-Giglou; Annabelle Santos Volgman; Hena Patel; Susan Campbell; Amparo Villablanca; Eileen Hsich
Journal:  J Womens Health (Larchmt)       Date:  2017-07-17       Impact factor: 2.681

Review 4.  Identifying the Critical Gaps in Research on Sex Differences in Metabolism Across the Life Span.

Authors:  Jane E B Reusch; T Rajendra Kumar; Judith G Regensteiner; Philip S Zeitler
Journal:  Endocrinology       Date:  2018-01-01       Impact factor: 4.736

Review 5.  Genetics of paediatric cardiomyopathies.

Authors:  Stephanie M Ware
Journal:  Curr Opin Pediatr       Date:  2017-10       Impact factor: 2.856

6.  Fine mapping titin's C-zone: Matching cardiac myosin-binding protein C stripes with titin's super-repeats.

Authors:  Paola Tonino; Balazs Kiss; Jochen Gohlke; John E Smith; Henk Granzier
Journal:  J Mol Cell Cardiol       Date:  2019-05-31       Impact factor: 5.000

7.  Global Left Ventricular Strain at Presentation Is Associated with Subsequent Recovery in Patients with Peripartum Cardiomyopathy.

Authors:  Masataka Sugahara; Nobuyuki Kagiyama; Nina E Hasselberg; Lori A Blauwet; Joan Briller; Leslie Cooper; James D Fett; Eileen Hsich; Gretchen Wells; Dennis McNamara; John Gorcsan
Journal:  J Am Soc Echocardiogr       Date:  2019-09-25       Impact factor: 5.251

Review 8.  Peripartum Cardiomyopathy: a Review for the Clinician.

Authors:  Abigail Khan; Emmanuelle Paré; Shimoli Shah
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-09-29

Review 9.  Genetics of inherited cardiomyopathies in Africa.

Authors:  Gasnat Shaboodien; Timothy F Spracklen; Stephen Kamuli; Polycarp Ndibangwi; Carla Van Niekerk; Ntobeko A B Ntusi
Journal:  Cardiovasc Diagn Ther       Date:  2020-04

Review 10.  Dilated Cardiomyopathy: Genetic Determinants and Mechanisms.

Authors:  Elizabeth M McNally; Luisa Mestroni
Journal:  Circ Res       Date:  2017-09-15       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.